Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 4:09 AM
Ignite Modification Date: 2025-12-25 @ 4:09 AM
NCT ID: NCT01213420
Eligibility Criteria: Inclusion Criteria: * Patients must have two similar donor sites regarding location, depth and wound treatment. * Healing time of both donor sites may differ by 5 days maximum. * Patient compliance with therapy in relation to the protocol is necessary. In case of paediatric patients this depends on the collaboration of the parents. * For the two donor sites to be compared, the entire after-treatment concerning pressure garments or eventual silicone sheets must be equal for both donor sites. Pressure garments and/or silicone sheets are used only in case of burn wounds within the same location. * Patients must be available for regular and necessary follow-up (up to 6 months post healing). * Possibility to finish all measurements during follow-up visits. * Written authorisation of the patient, family or parents is required. Exclusion Criteria: * Donor sites are not similar (not identical in: depth, wound treatment, healing time). * The patient has a known allergy to Aloe Vera and/or to preservatives in cosmetic products. * The patient is not able to follow the complete treatment schedule. * The patient has any condition(s) that seriously compromises the patient's ability to complete this study. * The occurrence of a traumatic wound over the healed donor site (e.g. abrasion, skin tear, …) * The patient wishes to terminate the study. * No informed consent before start of the trial.
Healthy Volunteers: False
Sex: ALL
Study: NCT01213420
Study Brief:
Protocol Section: NCT01213420